Self-tolerance checkpoints in CD4 T cells specific for a peptide derived from the B cell antigen receptor

Journal of Immunology

Volumn 187, Issue 1, 2011, Pages 82-91

  Detanico, Thiago ^a,b   Heiser, Ryan A ^a   Aviszus, Katja ^a   Bonorino, Cristina ^b   Wysocki, Lawrence J ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTYLISOLEUCYLGLUTAMINYLMETHIONYLTHREONYLGLUTAMINYLISOLEUCYLPROPYLSERYLSERYLLEUCYLSERYLARGININE; B CELL ANTIGEN RECEPTOR; IMMUNOGLOBULIN KAPPA CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BONE MARROW; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL MIGRATION; CELL SURVIVAL; CHIMERA; CLONAL ANERGY; CONTROLLED STUDY; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGICAL TOLERANCE; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMOCYTE; TRANSGENE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MICE; MICE, INBRED A; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; RADIATION CHIMERA; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SELF TOLERANCE;

EID: 79960424328     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002287     Document Type: Article

References (52)

1. Griffiths, G. M., C. Berek, M. Kaartinen, and C. Milstein. 1984. Somatic mutation and the maturation of immune response to 2-phenyl oxazolone. Nature 312: 271-275. (Pubitemid 15202003)
2. Jacob, J., J. Przylepa, C. Miller, and G. Kelsoe. 1993. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells. J. Exp. Med. 178: 1293-1307.
3. Wysocki, L., T. Manser, and M. L. Gefter. 1986. Somatic evolution of variable region structures during an immune response. Proc. Natl. Acad. Sci. USA 83: 1847-1851.
4. Casson, L. P., and T. Manser. 1995. Random mutagenesis of two complementarity determining region amino acids yields an unexpectedly high frequency of antibodies with increased affinity for both cognate antigen and autoantigen. J. Exp. Med. 182: 743-750.
5. Snyder, C. M., X. Zhang, and L. J. Wysocki. 2002. Negligible class II MHC presentation of B cell receptor-derived peptides by high density resting B cells. J. Immunol. 168: 3865-3873.
6. Rudensky, A. Y., S. M. Mazel, J. M. Blechman, and V. L. Yurin. 1990. Immunoglobulin-specific T-B cell interaction. IV. B cell presentation of idiotypic determinant(s) of monoclonal anti-surface immunoglobulin antibody to idiotope-recognizing helper T clones. Eur. J. Immunol. 20: 1691-1696.
7. Munthe, L. A., J. A. Kyte, and B. Bogen. 1999. Resting small B cells present endogenous immunoglobulin variable-region determinants to idiotope-specific CD4(+) T cells in vivo. Eur. J. Immunol. 29: 4043-4052.
8. Bikoff, E. K., H. Yu, and L. A. Eckhardt. 1988. T cell recognition of endogenous IgG2a expressed in B lymphoma cells. Eur. J. Immunol. 18: 341-348.
9. Benaroch, P., and G. Bordenave. 1989. T cell-induced Ig allotypic suppression in mice. II. Both CD4+ CD8- and CD4- CD8+ T cell subsets from sensitized Igha mice are required to induce suppression of Igh-1b allotype expression. J. Immunol. 142: 1-7.
10. Weiss, S., and B. Bogen. 1991. MHC class II-restricted presentation of intracellular antigen. Cell 64: 767-776. (Pubitemid 121001164)
11. Weiss, S., and B. Bogen. 1989. B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells. Proc. Natl. Acad. Sci. USA 86: 282-286.
12. Bartnes, K., and K. Hannestad. 1997. Engagement of the B lymphocyte antigen receptor induces presentation of intrinsic immunoglobulin peptides on major histocompatibility complex class II molecules. Eur. J. Immunol. 27: 1124-1130.
13. Mitchison, N. A. 1971. The carrier effect in the secondary response to haptenprotein conjugates. V. Use of antilymphocyte serum to deplete animals of helper cells. Eur. J. Immunol. 1: 68-75.
14. Snyder, C. M., K. Aviszus, R. A. Heiser, D. R. Tonkin, A. M. Guth, and L. J. Wysocki. 2004. Activation and tolerance in CD4(+) T cells reactive to an immunoglobulin variable region. J. Exp. Med. 200: 1-11.
15. Munthe, L. A., A. Os, M. Zangani, and B. Bogen. 2004. MHC-restricted Ig V region-driven T-B lymphocyte collaboration: B cell receptor ligation facilitates switch to IgG production. J. Immunol. 172: 7476-7484. (Pubitemid 38747610)
16. Eyerman, M. C., X. Zhang, and L. J. Wysocki. 1996. T cell recognition and tolerance of antibody diversity. J. Immunol. 157: 1037-1046.
17. Guo, W., D. Smith, A. Guth, K. Aviszus, and L. J. Wysocki. 2005. T cell tolerance to germline-encoded antibody sequences in a lupus-prone mouse. J. Immunol. 175: 2184-2190.
18. Bogen, B., Z. Dembic, and S. Weiss. 1993. Clonal deletion of specific thymocytes by an immunoglobulin idiotype. EMBO J. 12: 357-363. (Pubitemid 23042415)
19. Lauritzsen, G. F., P. O. Hofgaard, K. Schenck, and B. Bogen. 1998. Clonal deletion of thymocytes as a tumor escape mechanism. Int. J. Cancer 78: 216-222. (Pubitemid 28443180)
20. Rueff-Juy, D., M. Faure, A. M. Drapier, and P. A. Cazenave. 1998. Role of maternal Ig in the induction of C kappa-specific CD8+ T cell tolerance. J. Immunol. 161: 721-728.
21. Huseby, E. S., J. White, F. Crawford, T. Vass, D. Becker, C. Pinilla, P. Marrack, and J. W. Kappler. 2005. How the T cell repertoire becomes peptide and MHC specific. Cell 122: 247-260.
22. Guth, A., T. Detanico, D. Smith, K. S. Tung, C. Bonorino, and L. J. Wysocki. 2009. Spontaneous autoimmunity in mice that carry an IghV partial transgene: a required arginine in VHCDR3. Lupus 18: 299-308.
23. Lyons, A. B., and C. R. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171: 131-137.
24. Marshak-Rothstein, A., M. Siekevitz, M. N. Margolies, M. Mudgett-Hunter, and M. L. Gefter. 1980. Hybridoma proteins expressing the predominant idiotype of the antiazophenylarsonate response of A/J mice. Proc. Natl. Acad. Sci. USA 77: 1120-1124.
25. Dyall, R., and J. Nikolić-Zugić. 1995. The majority of postselection CD4+ single-positive thymocytes requires the thymus to produce long-lived, functional T cells. J. Exp. Med. 181: 235-245.
26. Seddon, B., and D. Mason. 1999. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J. Exp. Med. 189: 877-882.
27. Jordan, M. S., A. Boesteanu, A. J. Reed, A. L. Petrone, A. E. Holenbeck, M. A. Lerman, A. Naji, and A. J. Caton. 2001. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2: 301-306.
28. Apostolou, I., A. Sarukhan, L. Klein, and H. von Boehmer. 2002. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3: 756-763.
29. Taguchi, O., K. Kontani, H. Ikeda, T. Kezuka, M. Takeuchi, T. Takahashi, and T. Takahashi. 1994. Tissue-specific suppressor T cells involved in self-tolerance are activated extrathymically by self-antigens. Immunology 82: 365-369. (Pubitemid 24251617)
30. Masteller, E. L., M. R. Warner, Q. Tang, K. V. Tarbell, H. McDevitt, and J. A. Bluestone. 2005. Expansion of functional endogenous antigen-specific CD4 +CD25+ regulatory T cells from nonobese diabetic mice. J. Immunol. 175: 3053-3059.
31. Teh, H. S., H. Kishi, B. Scott, and H. Von Boehmer. 1989. Deletion of auto-specific T cells in T cell receptor (TCR) transgenic mice spares cells with normal TCR levels and low levels of CD8 molecules. J. Exp. Med. 169: 795-806.
32. Illés, Z., H. Waldner, J. Reddy, A. C. Anderson, R. A. Sobel, and V. K. Kuchroo. 2007. Modulation of CD4 co-receptor limits spontaneous autoimmunity when high-affinity transgenic TCR specific for self-antigen is expressed on a genetically resistant background. Int. Immunol. 19: 1235-1248.
33. Furmanski, A. L., I. Bartok, J. G. Chai, Y. Singh, C. Ferreira, D. Scott, S. J. Holland, C. Bourdeaux, T. Crompton, and J. Dyson. 2010. Peptide-specific, TCR-alpha-driven, coreceptor-independent negative selection in TCR alpha-chain transgenic mice. J. Immunol. 184: 650-657.
34. Russell, J. H., P. Meleedy-Rey, D. E. McCulley, W. C. Sha, C. A. Nelson, and D. Y. Loh. 1990. Evidence for CD8-independent T cell maturation in transgenic mice. J. Immunol. 144: 3318-3325.
35. von Boehmer, H., J. Kirberg, and B. Rocha. 1991. An unusual lineage of alpha/ beta T cells that contains autoreactive cells. J. Exp. Med. 174: 1001-1008.
36. Girgis, L., M. M. Davis, and B. Fazekas de St Groth. 1999. The avidity spectrum of T cell receptor interactions accounts for T cell anergy in a double transgenic model. J. Exp. Med. 189: 265-278.
37. Akkaraju, S., W. Y. Ho, D. Leong, K. Canaan, M. M. Davis, and C. C. Goodnow. 1997. A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity 7: 255-271.
38. Teague, R. M., P. D. Greenberg, C. Fowler, M. Z. Huang, X. Tan, J. Morimoto, M. L. Dossett, E. S. Huseby, and C. Ohlén. 2008. Peripheral CD8+ T cell tolerance to self-proteins is regulated proximally at the T cell receptor. Immunity 28: 662-674.
39. Eck, S. C., P. Zhu, M. Pepper, S. J. Bensinger, B. D. Freedman, and T. M. Laufer. 2006. Developmental alterations in thymocyte sensitivity are actively regulated by MHC class II expression in the thymic medulla. J. Immunol. 176: 2229-2237.
40. Stephen, T. L., A. Tikhonova, J. M. Riberdy, and T. M. Laufer. 2009. The activation threshold of CD4+ T cells is defined by TCR/peptide-MHC class II interactions in the thymic medulla. J. Immunol. 183: 5554-5562.
41. Davey, G. M., S. L. Schober, B. T. Endrizzi, A. K. Dutcher, S. C. Jameson, and K. A. Hogquist. 1998. Preselection thymocytes are more sensitive to T cell receptor stimulation than mature T cells. J. Exp. Med. 188: 1867-1874.
42. Bautista, J. L., C. W. Lio, S. K. Lathrop, K. Forbush, Y. Liang, J. Luo, A. Y. Rudensky, and C. S. Hsieh. 2009. Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat. Immunol. 10: 610-617.
43. Wirnsberger, G., F. Mair, and L. Klein. 2009. Regulatory T cell differentiation of thymocytes does not require a dedicated antigen-presenting cell but is under T cell-intrinsic developmental control. Proc. Natl. Acad. Sci. USA 106: 10278-10283.
44. Fontenot, J. D., J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 202: 901-906.
45. Bensinger, S. J., A. Bandeira, M. S. Jordan, A. J. Caton, and T. M. Laufer. 2001. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J. Exp. Med. 194: 427-438.
46. Josefowicz, S. Z., and A. Rudensky. 2009. Control of regulatory T cell lineage commitment and maintenance. Immunity 30: 616-625.
47. Olivares-Villagómez, D., Y. Wang, and J. J. Lafaille. 1998. Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J. Exp. Med. 188: 1883-1894.
48. Bollyky, P. L., J. D. Lord, S. A. Masewicz, S. P. Evanko, J. H. Buckner, T. N. Wight, and G. T. Nepom. 2007. Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells. J. Immunol. 179: 744-747.
49. Fisson, S., G. Darrasse-Jèze, E. Litvinova, F. Septier, D. Klatzmann, R. Liblau, and B. L. Salomon. 2003. Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J. Exp. Med. 198: 737-746.
50. Firan, M., S. Dhillon, P. Estess, and M. H. Siegelman. 2006. Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44. Blood 107: 619-627.
51. Darrasse-Jèze, G., S. Deroubaix, H. Mouquet, G. D. Victora, T. Eisenreich, K. H. Yao, R. F. Masilamani, M. L. Dustin, A. Rudensky, K. Liu, and M. C. Nussenzweig. 2009. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 206: 1853-1862.
52. Darrasse-Jèze, G., A. S. Bergot, A. Durgeau, F. Billiard, B. L. Salomon, J. L. Cohen, B. Bellier, K. Podsypanina, and D. Klatzmann. 2009. Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice. J. Clin. Invest. 119: 2648-2662.